Protection against group B Neisseria meningitidis disease: preparation of soluble protein and protein-polysaccharide immunogens
about
Gonococcal transferrin-binding protein 1 is required for transferrin utilization and is homologous to TonB-dependent outer membrane receptors.Correlation between serological and sequencing analyses of the PorB outer membrane protein in the Neisseria meningitidis serotyping system.Function of neisserial outer membrane phospholipase a in autolysis and assessment of its vaccine potentialPurification and comparison of outer membrane protein P2 from Haemophilus influenzae type b isolates.Meningococcal lipopolysaccharide (LPS)-derived oligosaccharide-protein conjugates evoke outer membrane protein- but not LPS-specific bactericidal antibodies in mice: influence of adjuvants.Characterization and acceptor preference of a soluble meningococcal group C polysialyltransferase.Sequence of the structural gene (rmpM) for the class 4 outer membrane protein of Neisseria meningitidis, homology of the protein to gonococcal protein III and Escherichia coli OmpA, and construction of meningococcal strains that lack class 4 proteinModulation of the biological activities of meningococcal endotoxins by association with outer membrane proteins is not inevitably linked to toxicity.Protection against group B Neisseria meningitidis disease: effect of serogroup B polysaccharide and polymyxin B on immunogenicity of serotype protein preparationsCurrent status of meningococcal group B vaccine candidates: capsular or noncapsular?A pleiotropic iron-uptake mutant of Neisseria meningitidis lacks a 70-kilodalton iron-regulated protein.Loss of transferrin receptor activity in Neisseria meningitidis correlates with inability to use transferrin as an iron sourceImmune responses in mice to different noncovalent complexes of meningococcal B polysaccharide and outer membrane proteins.Immunoresponses to Neisseria meningitidis epitopes: suppression of secondary response to phosphorylcholine is carrier specificEffect of aluminum ions on chemical and immunological properties of meningococcal group B polysaccharideDevelopment of a Neisseria meningitidis group B serotype 2b protein vaccine and evaluation in a mouse modelHuman opsonins to meningococci after vaccination.Human antibody response to a group B serotype 2a meningococcal vaccine determined by immunoblotting.Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.Antibody responses to serogroup B meningococcal outer membrane antigens after vaccination and infection.NZB mouse system for production of monoclonal antibodies to weak bacterial antigens: isolation of an IgG antibody to the polysaccharide capsules of Escherichia coli K1 and group B meningococci.Characterization of a stress protein from group B Neisseria meningitidis.Involvement of phospholipid end groups of group C Neisseria meningitidis and Haemophilus influenzae type b polysaccharides in association with isolated outer membranes and in immunoassays.Specificity of antibodies to O-acetyl-positive and O-acetyl-negative group C meningococcal polysaccharides in sera from vaccinees and carriers.Activation of murine B lymphocytes by Neisseria meningitidis and isolated meningococcal surface antigens.Peptides bound to proteosomes via hydrophobic feet become highly immunogenic without adjuvants.
P2860
Q30451836-B3261F4B-F46A-4B44-B5C2-F6E827BE21DEQ33655041-31580C11-996B-4B09-947C-9D1E99B67BA3Q33769469-E61B0ABC-5785-4C3F-8A1F-2866E4374FAEQ33822126-363417DC-D15E-4D7E-85C9-11DEA8681CAAQ34521522-8FB51E82-BBBD-4F85-B662-DE083E1F9585Q34740881-8843D111-AA38-4ADC-966E-1B17B494576EQ35111410-CAE49E0B-7347-43D5-AA2C-F41ADCB25CDBQ35547781-977DD9ED-5252-4B15-AE2F-C7CB9EF5D21CQ36329652-D59EB310-127E-491B-8BE2-3C713C5D44F7Q36642138-ED2D1759-B03F-4C46-8C5C-C274D40A46A4Q36996292-03F11E87-A0F5-4546-8F1E-A692412A5DFBQ37001974-05006682-FE5A-4879-B1B6-5728CFF69F80Q37002443-A0D57BE7-EE5A-40F4-8226-1849D2973C27Q37030722-DC436BF1-2D8B-4C6F-BA2A-4B69FA6BFC9DQ37032835-6ADF0E2D-49CE-405B-B4B5-B8E998ED5091Q37041494-8C8D54E0-0C13-4470-BE40-E9DE33BF28B7Q37042683-5781AD9C-F13D-49BD-89FF-B3DE675A9598Q37056736-3A1C9BC2-42A8-4BE2-9766-1B5807EE91E0Q37058833-D9E1B564-C998-4267-AD41-8B72490D8C49Q37152841-E9EB1174-1DBF-4CAA-8ED0-2325FD0278E2Q37678387-D2826CAE-7A91-4DFD-A8AA-6544FDFD8895Q39929015-40C8198B-79FC-4D76-A710-017F3FB20FE3Q39930389-2D3522A5-4903-4F77-8902-F08ABE0A7129Q40156159-F237A1EB-F542-4B9E-8662-DB2714C9D722Q40182351-684D59C4-2C5A-4F01-87BE-AA52028447E5Q42939044-B1FACF7B-AF4F-4F64-B74A-CA4F0A9007D3
P2860
Protection against group B Neisseria meningitidis disease: preparation of soluble protein and protein-polysaccharide immunogens
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年学术文章
@wuu
1982年学术文章
@zh-cn
1982年学术文章
@zh-hans
1982年学术文章
@zh-my
1982年学术文章
@zh-sg
1982年學術文章
@yue
1982年學術文章
@zh
1982年學術文章
@zh-hant
name
Protection against group B Nei ...... tein-polysaccharide immunogens
@ast
Protection against group B Nei ...... tein-polysaccharide immunogens
@en
type
label
Protection against group B Nei ...... tein-polysaccharide immunogens
@ast
Protection against group B Nei ...... tein-polysaccharide immunogens
@en
prefLabel
Protection against group B Nei ...... tein-polysaccharide immunogens
@ast
Protection against group B Nei ...... tein-polysaccharide immunogens
@en
P2860
P1476
Protection against group B Nei ...... tein-polysaccharide immunogens
@en
P2093
P2860
P304
P407
P577
1982-07-01T00:00:00Z